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Abstract
Background: The functioning of the nervous system depends upon the specificity of its synaptic contacts. The mechanisms
triggering the expression of the appropriate receptors on postsynaptic membrane and the role of the presynaptic partner in
the differentiation of postsynaptic structures are little known.
Methods and Findings: To address these questions we cocultured murine primary muscle cells with several glutamatergic
neurons, either cortical, cerebellar or hippocampal. Immunofluorescence and electrophysiology analyses revealed that
functional excitatory synaptic contacts were formed between glutamatergic neurons and muscle cells. Moreover,
immunoprecipitation and immunofluorescence experiments showed that typical anchoring proteins of central excitatory
synapses coimmunoprecipitate and colocalize with rapsyn, the acetylcholine receptor anchoring protein at the
neuromuscular junction.
Conclusions: These results support an important role of the presynaptic partner in the induction and differentiation of the
postsynaptic structures.
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Introduction
The efficacy of synaptic transmission depends upon the mecha-
nisms that regulate the assembly of the pre- and postsynaptic
components. Most of our knowledge about the formation of
synapses comes from studies of vertebrate neuromuscular junction
(NMJ). At the NMJ, it is well established that the nerve-derived
factor z-agrin, plays a predominant role in organizing numerous
aspects of postsynaptic differentiation [1,2,3,4]. Agrin activates
LRP4/MuSK in the muscle fiber, leading to local synthesis and
aggregation of acetylcholine receptors (AChRs) [5,6,7,8,9,10,11,12].
Neuregulin, another molecule released from the nerve, was also
proposed to induce AChRs synthesis from subsynaptic muscle nuclei
through activation of ErbB receptor tyrosine kinases [13]. However,
mice deficient in ErbB receptor tyrosine kinase have no defect in
AChRs synthesis [14].
At central synapses, several neuronal and glial secreted
synaptogenic molecules are implicated in the formation of post-
synaptic structures in the central nervous system (CNS). For
example EphrinB-EphB receptors, neuronal pentraxins (Narp),
Cbln1, thrombospondin ([15,16,17,18,19], see also some reviews
[20,21]). Despite our knowledge about the mechanisms that
regulate synaptogenesis in mammalian NMJ and interneuronal
synapses, it remains largely unknown how the matching between
neurotransmitter phenotype and the appropriate postsynaptic
receptor is obtained in developing synapses.
Recently, it has been shown that embryonic muscle cells of
Xenopus express several classes of transmitter receptors in ad-
dition to those for acetylcholine (ACh) [22]. When the presynaptic
neurotransmitter is changed, by altering electrical activity, neurons
can select the appropriate transmitter receptor from the
population available on the surface of muscle cells [23,24]. In
another study, Brunelli et al. have shown that in a particular
reinnervation model, in which descending glutamatergic fibers
were diverted from the spinal cord to rat skeletal muscle by means
of a peripheral nerve graft, the cholinergic synapses switch to the
glutamatergic type [25,26,27].
In this work, to further investigate the role of presynaptic
structure in the differentiation of the postsynaptic elements and to
achieve the precise synaptic development, we cocultured, in
separate compartments of the same plate, murine primary muscle
cells with glutamatergic neurons. We found that primary
glutamatergic neurons form functional glutamatergic synapses
with skeletal muscle cells.
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Formation of synaptic contacts between glutamatergic
neurons and muscle cells
To evaluate whether different glutamatergic neurons are able
to form synapses with myotubes, a non-physiological synaptic
partner, we cocultured myotubes for 7–9 days with neurons ob-
tained by different brain areas: cortex, cerebellum and hippo-
campus. In particular, to facilitate the immunofluorescence and
electrophysiology studies, we separated the two populations of cells
using two half teflon rings soaked in silicon grease and laid down
on the bottom of a Petri dish to obtain a Campenot-like chamber,
in which neurons were seeded inside the rings, whereas myotubes
were grown outside (see the scheme in Figure 1A). In such device,
neurons made synaptic contacts with each other but a pool of
axons were able to grow across the silicone grease/teflon barrier
and reach muscle cells. Preliminary experiments were performed
to find the optimal conditions to maintain soma of neurons
Figure 1. Cortical neurons form fully functional glutamatergic synapses with myotubes. In A a scheme of the coculture plate shows how
the stimulus was applied to axons crossing the teflon barrier. Calcium-dependent fluorescence variations (B) and myotube shortening during
contraction (C) have been measured during electrical stimulation while myotubes were sequentially bathed in saline, treated with Curare, treated
with AMPAR antagonist, and after washout. In B an example of myotube fluorescence is also shown for each condition. In all the experiments the
treatment with the AMPAR antagonist GYKI 52466 gave a complete block of calcium transients and myotube shortening, demonstrating that
synapses are functional and glutamatergic. N=3, *p,0,05, #p,0,01 by t-test (paired sample, 2 tailed).
doi:10.1371/journal.pone.0031451.g001
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obtained this, when the electric resistance between inside and
outside the teflon ring was about 15–20 kV [28].
Cocultured cells were fixed and immunostained for AMPA
receptors (GluR1 subunit), acetylcholine receptors (AChRs), axons
and presynaptic terminations (neurofilaments and synaptophysin
respectively). Axons of glutamatergic neurons were able to grow
and form contacts with muscle cells even if they were not the
physiological postsynaptic partners of glutamatergic neurons
(Figure 2 and Figure S1). AMPA receptor clusters were observed
at synaptic contacts between muscle and neurons, while AChRs,
the physiological postsynaptic receptor in muscle cells, displayed a
diffuse distribution. When cocultures of muscle and neurons were
stained with antibodies against NMDA receptors (anti-NMDA2B
subunit) or GABA receptors (anti-GAD 67), no staining was
observed (data not shown).
Moreover, cultures of neurons were immunostained to study
evaluate neurotransmitter phenotype in the cell culture. Gluta-
matergic (vescicular glutamate transporter type-2, anti-VGlut-2),
GABAergic (anti glutamic acid decarbossilase, anti-GAD67) and
cholinergic (anti choline acetyl transferase, anti-Chat) markers
were used. We found that about 95% of the neurons had
glutamatergic phenotype.
Time–course of the expression of glutamate receptors in
cocultured myotubes
Next, we examined the time course of GluR1 expression and
clustering in cocultured myotubes (Figure 3). To do this,
cocultured myotubes were stained for AMPARs, AChRs, and
for axons and terminations at 3 and 8 days after myotubes
differentiation. At 3 days, AMPA receptors were diffusely
expressed by the myotubes, some of which received multiple
contacts from axons (Figure 3 A–D). However, at 8 days, most
GluR1 were clustered at synaptic contacts, whereas non synaptic
AMPA receptors were eliminated (Figure 3 E–L), a behavior
resembling the physiological development of AChRs plaques in
muscles. In contrast to AMPA receptor clustering, AChRs were
found to be distributed on the entire cell surface at both day 3 and
day 8 as previously described in cocultured myotubes with
cerebellar granule cells [29]. To confirm that contact sites between
axons and muscle cells were glutamatergic excitatory synapses,
nerve terminals were stained at 8 days with VGluT2 (Figure 3 H–
L). This result indicates that most of synaptic sites were gluta-
matergic synapses.
To further investigate the anatomical distribution of AMPA
receptor clusters, we analyzed AMPAR staining on cocultured
muscle cells with either hippocampal (20 myotubes observed in 2
plates), cortical (27 myotubes observed in 3 plates), or cerebellar
neurons (37 myotubes). We found three types of AMPA receptor
profiles as follows: 1) widespread, 2) small clusters diffusely present
in the whole cell and 3) bigger clusters co-localized with the
synaptic contact. A possible explanation for the co-existence of
different AMPARs organization is that in our cocultures neurites
take a certain time to grow through the plate and thus they contact
myotubes with a different timing, depending on how far from the
teflon wall is the muscle cell.
Quantification of AMPARs organization shows that at 9 days
the 20% of myotubes did not express AMPARs, the 28%
expressed the receptors diffusely, the 50% of the cells displayed
clusters. Of these clusters, 20% were localized at synaptic sites.
Finally, we examined whether myotubes cultured without
neurons could express AMPA receptors. We stained primary
myotubes without neurons at 1–3-and 5 days post-differentiation
(Figure 4) for AMPARs and AChRs. We found that only AChRs
were expressed by the myotubes, and these AChRs displayed a
diffuse distribution, as usually happens in culture [2].
To determine whether AMPA receptors form complexes with
scaffold proteins including rapsyn, stargazin, SAP97 and PSD95,
we coimmunoprecipitated proteins interacting with rapsyn in
membrane preparations from myotubes in cocultures. Rapsyn is
the muscle protein anchoring AChRs at the plasmatic membrane
and it is essential for clustering AChRs at the postsynaptic
apparatus [30,31]. Membrane extracts from cocultured myotubes
with and without neurons were incubated with anti-rapsyn
antibody and the immunoprecipitated proteins were analyzed by
immunoblotting using antibodies against: 1) GluR1 AMPA
receptor subunit, 2) stargazin, the AMPA receptor interacting
protein at brain postsynaptic densities, 3) SAP97, the membrane-
associated guanylate kinases regulating the AMPA receptor
trafficking and 4) PSD95. Immunoblots analyses revealed that
GluR1 subunit is immuonoprecipated with rapsyn only in
myotubes that are in contact with neurons. However stargazin,
SAP97 and PSD95 are immunoprecipated with rapsyn in
myotubes cocultured with or without neurons (Figure 5). Con-
comitantly with the appearance of GluR1, the amount of stargazin
also increased in innervated muscle cells while SAP97 decreased,
as described previoulsy [25]. No changes were detected in PSD95
levels in myotubes with or without neurons. The post-synaptic
localization of AMPA receptors in myotubes cocultured with
neurons was further evidenced by the rapsyn immunoreactivity
detected in GluR1 immunoprecipitates from membrane proteins
(Figure 5). The presence of neuronal terminals in cocultured cells
was confirmed by the bIII-tubulin immunoreactivity detected in
cell extracts from myotube-neuron template but not in myotube
without neurons.
Moreover, to investigate the relative distribution of GluR1,
rapsyn, stargazin, SAP97 and PSD95 we immunostained cocul-
tured myotubes. Representative images are shown in Figure 5C.
In line with co-immunoprecipitation analysis, we found a
colocalization of rapsyn, with both GluR1 and stargazin. The
staining of PSD95 colocalized with GluR1 while SAP97 signal
showed a diffuse distribution.
Functional characterization of the synaptic contact
between myotubes and cortical glutamatergic neurons
To examine whether glutamatergic synapses in cocultures are
functional, we performed calcium imaging experiments and
shortening contraction imaging analysis. Cocultured myotubes at
8–9 days, were incubated with Fluo4-AM, a calcium fluorescence
probe, and changes in intracellular calcium were monitored
during electrical stimulation of axons crossing the teflon walls, as
shown in Figure 1A. In each coculture, about 8–10 myotubes were
activated by electrical stimulation. Stimulation produced fluores-
cence transients in basal conditions (i. e. in saline solution) and
after AChRs block by curare treatment, meaning that AChRs are
not the mediators of synaptic transmission. Importantly, in
presence of curare and an AMPAR antagonist (GYKI 52466)
fluorescence transients were abolished, whereas after their washing
out, calcium transients were restored (see Figure 1B and Movie
S1). In control experiments we tested whether the administration
of the AMPAR antagonist vehicle affected fluorescence signals
(n=4 cells) and whether the electrical pulse, used to stimulate
axons, induced direct activation of myotubes (n=3 cells). Both
experiments didn’t produce fluorescence changes in myotubes.
In a different group of cocultures (2 myotubes analyzed) only the
AMPAR antagonist was administered and immediately fluores-
cence transients were blocked. The wash out of GYKI 52466
restored fluorescence increases (Figure S2).
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31451Figure 2. Glutamatergic neurons from different brain areas form synaptic contacts with myotubes in vitro. Confocal images showing
synapses between myotubes and glutamatergic neurons from cortex (A–F), cerebellum (G–L) or hippocampus (M–O) after 9 days of coculture and
immunostained. AMPARs (GluR1 subunit) are in green, axonal neurofilaments and terminations are in red (NF, SV2), whereas AChRs are in cyan (a-
bungarotoxin). AChRs are diffusely distributed on myotube surface, whereas AMPARs form clusters that are often near to the axonal termination.
Scale bars 10 mm.
doi:10.1371/journal.pone.0031451.g002
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axon the calcium increase is followed by sarcomer contraction and
subsequent reduction of cell length. The same happened in
glutamatergic neuron-myotube cocultures. We quantified the
shortening of myotubes on video recordings, by measuring the
length variation of cells during electrical stimulation of axons
(n=3 myotubes). The results are plotted in Figure 1C. Axons were
stimulated with an electrical pulse of 4–8 V every 2 seconds. In
each coculture, 4–6 myotubes, at least, showed contraction.
Experimental protocol was the same of calcium imaging
experiment. Myotube contraction was observed in saline solution
and after curare administration, but not after AMPAR antagonist
treatment. The wash out of AMPAR antagonist restored myotube
activity (Figure 1C and Movie S2).
In a different group of cocultures we verified that vehicle so-
lution did not affect myotube activity (2 myotubes were studied).
To confirm the specificity of AMPA antagonism in inhibiting
myotube activity, in another group (2 myotubes analyzed), only
GYKI 52466 was administrated. Also in this case the contraction
was efficiently blocked.
All these data demonstrate that glutamatergic neurons are able
to form a fully functional synapse even with a non physiological
postsynaptic partner like myotubes.
Discussion
The present work shows that glutamatergic neurons have a
striking effect on the expression of neurotransmitter receptors of
mammalian muscle cells. Particularly, when myotubes were
cocultured with glutamatergic neurons, AMPARs were expressed
and clustered at synaptic sites, whereas some AChRs remained
diffusely distributed on the entire cell surface of the muscle cell and
others were aggregated spontaneously into hot spots. Conversely,
myotubes cultured without neurons did not express AMPARs but
only AChRs. In cocultures we saw that axons contacted myotubes
after the third day. At this day AMPARs were widely distributed
on the entire surface of muscle cells. Later, at 8th–9th day,
AMPARs clustered and colocalized with axon terminals. Our
biochemical and immunohistological results show that AMPARs
and their associated scaffold proteins present in the brain
Figure 3. Time course of synaptic contacts formation in cocultures. Examples of cortical neurons cocultured with myotubes for 3 (A–D) and 8
days (E–L), fixed, immunostained and studied by confocal microscopy. AMPARs (GluR1 subunit) are in green, axonal neurofilaments and terminations
are in red (NF, SV2). At 3 days AMPARs are diffusely distributed (A, C) and myotubes often receive multiple synaptic contacts (B, D). At 8 days AMPARs
form clusters (E, I) near or under the terminations (G, K). The Vesicular Glutamate transporter 2 (VGluT2, blue) confirm that the synaptic contact is
glutamatergic (H, L). Scale bars 10 mm.
doi:10.1371/journal.pone.0031451.g003
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complexes with rapsyn, a component of the scaffolding protein,
that it is required to receptor clustering. These data are consistent
with previously published work in which skeletal muscles are
surgically innervated by spinal glutamatergic fibers [25]. Analysis
of GluR1 immunoprecipitates revealed the presence of rapsyn in
membrane of myotube-neuron cocultures. In rapsyn-immunopre-
cipitates we detected GluR1 subunit together with stargazin, a
scaffolding protein necessary for the AMPA receptor targeting to
the synaptic membrane [32]. Confocal analysis of immunofluo-
rescence staining confirmed the co-localization of rapsyn with
either GluR1 or stargazin. Differently from stargazin, SAP97, the
key regulator of AMPA receptor trafficking, decreased in cocul-
tured myotubes when compared to pure myotubes cultures,
suggesting that in innervated muscle cells GluR1 subunits were
stably inserted at the postsynaptic membrane [33]. No change was
present in the PSD95 content of the myotubes cultured with and
without neurons, also confirming previous evidence [25,27]. These
data are further supported by electrophysiological analysis. In
calcium imaging experiments, electrical stimulation of axons
induced calcium increases in myotubes that were insensitive to
the AChR blocker, curare, but totally prevented by GYKI 52466,
the selective blocker of glutamate AMPA receptors [34,35]. Taken
together, these findings expand on previous evidence showing that
glutamatergic presynaptic terminals are able to induce a functional
postsynaptic membrane structure in muscle cells [25,27].
Synapse formation is the result of a complex and highly
regulated process of membrane and molecular interactions
between pre and postsynaptic components. Several works showed
the fundamental role of electrical activity, genetic and transcrip-
tion factors and signaling proteins in the synaptic assembling (see
for reviews [2,20,36,37,38,39]). However, one of the most
intriguing question about synaptogenesis is how the matching
between neurotransmitter phenotype and the appropriate post-
synaptic receptor is obtained. It has been hypothesized that this
process could arise in a number of different ways: 1) the
presynaptic terminal induces the expression of the appropriate
receptors in postsynaptic membrane independently on the
receptors already present on the membrane; 2) the postsynaptic
structure activates the expression of a wide range of receptors and
the presynaptic element chooses the appropriate receptor.
In support of the former idea, Brunelli et al. have shown that in
a particular reinnervation model, in which descending glutama-
tergic fibers of adult rat were diverted in the spinal cord to skeletal
muscle by means of a peripheral nerve graft, the cholinergic
synapses switch to the glutamatergic type [25,26,27]. Additionally,
Figure 4. Primary myotubes cultured without neurons do not express AMPARs. Primary myotubes were cultured in absence of neuron and
after differentiation, they were treated with the neuronal medium for 1 (A–C), 3 (D–F) and 5 (G–I) days. After fixation and staining for AMPARs (GluR1
subunit, central panels) and AChRs (a-bungarotoxin, left side panels), plates were acquired by confocal microscopy. Right side panels are the overlay
of left side and central panels. AchRs are diffusely and widely distributed on muscle surface (A, D, G), whereas no GluR1 positivity was found in all the
days examined (B, E, H). Scale bars 10 mm.
doi:10.1371/journal.pone.0031451.g004
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31451Spitzer et al. have shown that embryonic muscle cells of Xenopus
initially express several classes of transmitter receptors in addition
to those for ACh. During normal differentiation and innervation
of muscle, the other classes of receptors disappear. Changing the
expression of transmitters by altering calcium spike activity leads
to retention of the classes of cognate, non cholinergic receptors.
Under these conditions, they record glutamatergic, GABAergic,
and glycinergic synaptic currents from the skeletal muscle, as well
as those mediated by nicotinic AChRs [23,24]. The results of
Brunelli et al. suggest the presence of active mechanisms of
induction of receptors, while those of Spitzer et al. indicate a
mechanism of selection from a pool of receptors expressed during
the development from the target cells. Consistent with these
observations, our present studies strongly support the in vivo
observations that presynaptic terminal induces postsynaptic
structure to express the appropriate neurotransmitter receptor
also in target cells that usually don’t express its. Surprisingly, in
muscles cells glutamatergic neurons induce only AMPARs and not
others, suggesting that only some types of receptors are possibly
induced in target cells.
Thus, our and Spitzer observations suggest that mammals and
amphibians use different mechanisms to regulate the synaptic
specificity. An active role of the presynaptic terminal in the
mammals was also described in interneuronal synapses in the
cerebellum [40] and in the thalamus [41]. For reason unknown to
us, previous studies in chick muscle-neuron cocultures failed to
show a functional synapses between myotubes and supraspinal
glutamatergic neurons. For example, Obata observed end-plate
Figure 5. Glutamatergic synaptic components in cell membranes of cocultured myotubes. A: Membrane proteins co-immunoprecipitated
by anti-GluR1 antibody were analyzed by immunoblotting using rapsyn antibody. Results show that GluR1 strongly interacted with rapsyn only in
cocultured myotubes. Western blot analysis of beta III-tubulin confirmed the presence of neuronal cells only in coculture cell extracts. B: Membrane
proteins co-immunoprecipitated by anti-rapsyn antibody were analyzed by immunoblotting using antibodies against GluR1, SAP97, stargazin and
PSD95. Results show that both cocoltured myotubes and pure myotubes expressed PSD95, stargazin and SAP97 at the cell membrane. Conversely
GluR1 was strongly expressed only in cocultured myotubes. Immunoreactivity of rapsyn-interacting stargazin increased in cocoltured myotubes while
that of SAP97 decreased. No change was observed in PSD95 immunoreactivity. C: Confocal images showing the distribution of GluR1, rapsyn, SAP97,
stargazin and PSD95 in myotubes cocultured with neurons for 7 days and immunostained. Rapsyn, stargazin and PSD95 colocalize with the receptors,
while SAP97 shows a diffuse distribution.
doi:10.1371/journal.pone.0031451.g005
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chick spinal cord but not with chick cerebellum, cerebrum,
superior cervical ganglia or dorsal root ganglia [42].
The mechanisms by which glutamatergic innervations regulate
the expression of neurotransmitter receptor and the postsynaptic
differentiation are unknown. However, it is possible that the direct
contact between neurites and muscle cells may allow physical
interactions between membrane surface molecules, which in turn
may trigger intracellular signaling cascades, leading to changes in
postsynaptic receptor properties. In addition it is possible that
neurons may release diffusible factors that promote the clustering
of AMPARs. This latter is supported by the observation that
AMPARs are found to be distributed on the entire surface of
myotubes very distant from growth cone of axons. A candidate
anterograde neuronal factor could be Narp [16,17]. While it
remains unknown which factor (s) is released from nerve terminals,
our data excluded a role of glial factors since the percentage of
glial cells was very low (,2%). Another potential player in
postsynaptic differentiation is the neurotransmitter, but observa-
tions from Munc18-1-knockout and choline acetyltransferase-
knockout mice suggest that the initial assembly of the synapse may
proceed without neurotransmitter release [43,44]. It would be of
interest to define signals and molecular mechanisms responsible
for glutamatergic synapse formation and maintenance at mam-
malian NMJ.
The vertebrate NMJ has been characterized as cholinergic (see
for a review [2]). However, several reports have described the
expression in skeletal muscle cells of neurotransmitter receptors
other than the classical nicotinic receptors. Metabotropic gluta-
mate receptors have been described in the adult frog NMJ [45].
Recently, Mays et al. have described the presence of AMPA and
NMDA receptor subunits at the postsynaptic membrane of adult
NMJ in the mouse quadriceps [46]. The role of these transmitter
receptors is unclear, but the investigators suggested that they could
take part in the modulation of synaptic activity. In contrast to these
studies, our results showed that cultured muscle cells without
neurons did not express AMPA and/or NMDA receptors and we
did not observe the localization of AMPA and NMDA receptors in
the adult NMJ of rat abdominal skeletal muscle [25,27]. A
plausible explanation for the discrepancy with literature could be
that differences related to the expression level of receptor subtypes
may exist among diverse animal species and muscle types.
Methods
Ethics statement
All mice were treated in accordance with the policy of the
Italian Ministry of Health and European Community laws on the
use of animals in research. The procedures used were approved by
the CIRSAL (Interdepartmental Centre of Experimental Research
Service) of University of Verona.
Neuron-muscle cocultures. Skeletal muscle cells were
obtained from E18-E20 C57 mice embryos. Briefly, limbs were
collected in Ca
2+ and Mg
2+-free Hanks’ balanced salt solution.
Muscles were removed and cut into small pieces by microforceps.
After treatment with trypsin/DNase solutions for 30 min at 37uC
and dissociation through a Pasteur pipette, the cell suspension was
filtered through a cell strainer (BD Falcon 70 mm). Cells were
seeded (1200 cells/mm
2) in 35 mm Petri dishes (out of the Teflon
rings) previously coated with a gelatin and polylisine solution.
Culture medium was Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 10% Horse serum, 5% Fetal Calf
serum, Glutamine, Penicillin and Streptomycin. At confluency
myoblast fusion was induced by serum reduction. Cells were
maintained at 37uC and 5% CO2 [47]. After 4–5 days, when
myotubes start to contract, neurons were seeded inside the Teflon
rings.
Cortical neuron cultures: cortical neurons were purified from brain
of E18 C57 mice embryos. Briefly, fetal mouse brains were
removed under a dissecting microscope. After meninges removal,
cortices were collected and incubated with trypsin/DNase
solutions for 10 min at 37uC. Cells were mechanically dissociated
by trituration through a Pasteur pipette and seeded into the Teflon
rings (500 cells/mm
2) in Neurobasal Medium (Gibco), supple-
mented with B-27 (Gibco), Glutamine, Penicillin and Streptomy-
cin [48].
Hippocampal neuron cultures: Hippocampi were collected from
brain embryos and processed as described for cortices with only
slight differences: the growth medium was added with 0,01 mM
glutamate and the chemical dissociation was made without DNAse
[48].
Cerebellar granule cultures. Cerebella were dissected from P4–6
mice. After meninges removal cerebella were collected in a
solution of 35 mM glucose, 2,5 mM HEPES pH 7,4, 4 mM
NaHCO3 in HBSS (HHGN). Cerebella were washed 3 times with
HHGN and incubated in a solution of 10 mg/ml Trypsin,
0,1 mg/ml DNAse in HHGN for 10 min at 37uC. After 3 HHGN
washes, the tissue was mechanically dissociated in Basal Medium
Eagle (BME) containing 0,1 mg/ml DNAse. The suspension was
centrifuged at 200 g for 5 min and the pellet was resuspended in
the growth medium (BME supplemented with 10% Bovine
Growth Serum, 25 mM KCl, 2 mM glutamine, 100 U/ml
penicillin/streptomycin) and triturated again. Cells were plated
at a density of 2,5610
5 cells/cm
2 and 10 mM AraC was added to
the medium. After 3 days the medium was added with 25 mM
glucose [49,50]. All cocultures were maintained at 37uCi n5 %
CO2 in neuronal medium. Half medium was replaced every
3 days.
Immunofluorescence analysis
For immunofluorescence studies, cocultures were fixed with 4%
paraformaldeyde for 30 min at 4uC. After PBS washes cultures
were treated overnight at 4uC with primary antibodies (Abs) and
Alexa Fluor conjugated bungarotoxin in blocking solution (2%
serum, 2% Bovine Serum Albumin, 0.1% Triton 6100 in PBS).
After washes cells were treated with Alexa Fluor conjugated
secondary Abs diluted in blocking solution. After washes cells were
mounted with glycerol based antifading medium and coverslipped.
Images were acquired with Leica SP5 confocal microscope (Leica
Microsystem, Manheim, Germany).
Primary Abs used were: anti-GluR1 (Rabbit, 1:100, Chemicon),
anti-VGlut1 and 2 (Rabbit, 1:1000, SYSY), anti-Neurofilaments
SMI312 (mouse IgG1, 1:1000, Sternberger Monoclonals Incor-
porated), anti-synaptophysin (IgG1, 1:500, Chemicon) anti-SAP97
(1:2000, rabbit polyclonal, Affinity BioReagent Inc. Golden CO),
anti-PSD95 (1:2000, mouse monoclonal, Affinity BioReagent Inc.
Golden CO), anti-stargazin (1:1000, rabbit polyclonal, Upstate)
and anti-rapsyn (1:2000 mouse monoclonal, Affinity BioReagent
Inc. Golden CO).
Alpha-Bungarotoxin and the secondary Abs goat anti-rabbit
and goat anti-mouse IgG1, were all Alexa Fluor conjugated
(1:1000, Invitrogen) linked to A488, A568 and A647 fluorophores.
Calcium Imaging
Axons crossing the Teflon wall were stimulated by platinum
electrodes and calcium intracellular changes were monitored in
myotubes.
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for 60 min at 37uC in the recording solution (128 mM NaCl,
4 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 45 mM sucrose, 10 mM
glucose and 0,01 M HEPES; pH 7,4) in presence of Fluo4-AM
(Invitrogen) and pluronic F-127 (Invitrogen). After, extracellular
Fluo4-AM was removed and cocultures were incubated for 30 min
at 37uC with the recording solution to allow a complete de-
esterification of intracellular Fluo4-AM. Fluorescence variations
were acquired with 206 objective using an inverted microscope
(Zeiss Axiovert 35 M) equipped with a cooled CCD camera
(Qimaging Retiga-SRV fast, QED InVivo software) at a frequency
of 4 frame/s. Excitation of Fluo4 is 488 nm and emission was
collected at 510 nm [51].
Shortening contraction imaging analysis
Axons crossing teflon wall were stimulated using an electrical
pulse of 4–8 V of amplitude and 200 msec of duration every
2 seconds. Coculture medium was replaced with recording
solution (128 mM NaCl, 4 mM KCl, 1 mM CaCl2,1 m M
MgCl2, 45 mM sucrose, 10 mM glucose and 0,01 M HEPES;
pH 7,4). Myotubes were stimulated 30 seconds, before the
addition of the drugs, to record basal contraction. After D-
tubocurarine (AChR antagonist, 2610
26 g/ml) was administrated
and finally GYKI 52466 (AMPA receptor antagonist, 10 mM) was
added. Contraction was monitored 80 seconds in presence of
curare and 60 seconds in presence of AMPA receptor antagonist.
In control experiments only GYKI 52466 was administrated and
then it was removed. Myotube contraction was recorded by a 206
objective mounted on an inverted microscope (Zeiss Axiovert
35 M). Images were captured with cooled CCD camera (Qima-
ging Retiga-SRV fast-1394) at an acquisition rate of 4 frames/s
using QED InVivo software (Mediacybernetics). Myotube length
was evaluated by ImageJ software.
Co-immunoprecipitation
Only for coimmunoprecipitation studies we didn’t use Campe-
not like chamber. Cocultures were realized seeding cortical
neurons over myotubes. Myotubes from pure cultures and
myotube-neuronal cultures (36106 cells) were collected and
homogenized by sonication (twice for 10 sec each, at 10 kHz) in
500 ml cold buffer-A containing 0.32 M sucrose, 1 mM HEPES,
1 mM MgCl2, 10 mM NaHCO3, and 0.1 mM phenylmethylsul-
fonyl fluoride (PMSF) (pH 7.4) in the presence of a complete set of
protease inhibitors (Complete; Boehringer Mannheim GmbH,
Mannheim, Germany) and phosphatase inhibitors. Homogenates
were centrifuged at 13,000 g for 15 min at 4uC and the pellets
containing the membrane fractions were separated from cell
extracts and suspended in 300 ml cold buffer-B containing 50 mM
NaCl, 30 mM triethanolamine, 50 mM NaF, 5 mM EGTA,
5 mM EDTA, 10 mM phospho-nitrophenylphosphate, 50 mM
phenylarsine-oxide, 1 mM benzamide, 1 mM N-ethylmaleimide,
1 mM Na-tetrathionate, 1% NP40 Igepal, phosphatase inhibitors
and protease inhibitors cocktail. Membrane extracts (40 mg) were
precleared in 150 ml buffer-B plus 20 ml protein A/G (Santa Cruz
Biotechnology, CA) and rotated for 30 min at 4uC. After
centrifugation at 1000 g the supernatant was separated and
rotated overnight at 4uC in the presence of rabbit anti-GluR1anti-
body (1,5 mg, Chemicon) or monoclonal anti-rapsyn antibody
(2 mg, Affinity BioReagent Inc. Golden CO). Normal rabbit IgG
(Chemicon) was used as control negative antiserum. Thereafter,
protein A/G (25 ml) was added and the mixture was rotated for
2 h at 4uC. The beads were washed five times with RIPA buffer
(10 mM tris-HCl pH 8, 140 mM NaCl, 0.5% (v/v), Nonidet P-40,
1 mM sodium orthovanodate, 1% protease inhibitor cocktail) and
centrifuged at 1000 g for 5 min. Beads were added to SDS loading
buffer and boiled for 2 min. After centrifugation, supernatants
were immunoblotted using antibodies against: GluR1 (1:100,
rabbit polyclonal, Chemicon), SAP97 (1:2000, rabbit polyclonal,
Affinity BioReagent Inc. Golden CO), PSD95 (1:2000, mouse
monoclonal, Affinity BioReagent Inc. Golden CO), stargazin
(1:1000, rabbit polyclonal, Upstate) and rapsyn (1:2000 mouse
monoclonal, Affinity BioReagent Inc. Golden CO). The bIII–
tubulin immunoreativity (1:1000, rabbit polyclonal, Covance) is
tested in cell extracts from pure myotubes and myotubes-neuronal
cocultures.
Supporting Information
Figure S1 Examples of bright field images showing
myotubes cocultured with cortical neurons. The synaptic
contact is shown in the left panels and enlarged in the right images.
Scale bars 20 mmi nA ,C ,1 0mm in B, F and E, 5 mmi nD .
(TIF)
Figure S2 AMPAR antagonist inhibits calcium increase
in myotubes. Specificity of AMPA antagonist to inhibit myotube
activity was shown in calcium imaging experiments in which only
GYKI 52466, AMPAR antagonist, was administrated. Fluores-
cence variations were evaluated during electrical stimulation while
myotubes were sequentially bathed in saline, treated with AMPAR
antagonist, and after washout. Figure also shows myotube
fluorescence signal in each condition. In all experiments GYKI
52466 administration induced a complete inhibition of Ca release
highlighting the presence of pure glutamatergic synapse.
(TIF)
Movie S1 Movie shows a myotube during Calcium imaging
experiment. Calcium fluorescence increasing, after electrical
stimulation of axons, was observed in saline solution and after
curare administration. AMPAR antagonist treatment induced
block of the fluorescence variations, the washout of the antagonist
restored the fluorescence response.
(MOV)
Movie S2 Movie shows an example of glutamatergic innervated
myotube that following electrical stimulation of axons showed
contraction in saline solution and after curare administration. The
administration of AMPAR antagonist quickly inhibited myotube
contraction, it was reestablished washing out the antagonists
receptors.
(MOV)
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